CYP19A1 and breast carcinoma: Estrogen, which acts through ER, is thought to be a major etiological factor in breast cancer, and currently therapies include inhibitors of the ER and an estrogen-producing enzyme, cytochrome P450 19A1 (CYP19A1; aromatase).